Application of acteoside to preparation of drugs for preventing nerve cell injuries caused by neurotrophic factors (NTFs) and receptors thereof
A technology for nerve cell damage and neurotrophic factors, applied in drug combinations, nervous system diseases, pharmaceutical formulations, etc.
Inactive Publication Date: 2014-11-19
新疆维吾尔自治区维吾尔医药研究所
View PDF1 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
[0006]However, there is currently no literature report or disclosure about the enhancing effect of acteoside on neurotrophic factors and their receptors
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0067] Example 1, an application of acteoside-like in the preparation of a drug for protecting nerve cell damage caused by neurotrophic factors and their receptors.
Embodiment 2
[0068] Example 2, as an optimization of the above example, the neurotrophic factor in Example 2 is more than one of NGF, BDNF and NT-3.
Embodiment 3
[0069] Example 3, as an optimization of the above example, the neurotrophic factor receptor in Example 3 is TrkA or / and TrkB.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More PUM
Login to View More
Abstract
The invention relates to the technical field of neurotrophic factors (NTFs) and in particular relates to an application of acteoside to preparation of drugs for preventing nerve cell injuries caused by the NTFs and receptors thereof. Acteoside can obviously improve the expression of mRNA of NT-3, NGF and BDNF in brain tissues of female Kunming mice in model groups and the receptor TrkB of the BDNF, increase the protein content of the BDNF and TrkB in the brains and reinforce the protein expression levels of NT-3 and the NGF in the cortices and hippocampi of the brain tissues and the receptor TrkA of the NGF, indicating that acteoside has the function of reinforcing the NTFs and the receptors, can alleviate nerve cell injuries caused by reduction of expressions of the NTFs and the receptors thereof and has obviously better effects than vitamin E (VE) groups and piracetam tablet groups.
Description
technical field [0001] The invention relates to the technical field of neurotrophic factors, and relates to the application of acteosides in the preparation of drugs for protecting neurotrophic factors and their receptors from nerve cell damage. Background technique [0002] Neurotrophic factors (neurotrophic factors, NTFs) are a class of polypeptides or proteins produced by the body that can promote the survival, growth and differentiation of nerve cells. They not only regulate the survival of neurons during development, but also activate the activity of enzymes in biochemical and physiological Physiological function, but also prevent the death of adult neurons after injury, promote neuron repair, axon regeneration, regulate synaptic plasticity and neurotransmitter and other nervous system activities. There are five related factors that regulate neurons: nerve growth factor (nerve growth factor, NGF), brain-derived neurotrophic factor (brain-derived neurotrophic factor, ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More Application Information
Patent Timeline
Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7032A61P25/00
Inventor 闫明高莉彭晓明霍仕霞
Owner 新疆维吾尔自治区维吾尔医药研究所
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com